Presmed Australia has been acquired by ICG
Advanced Health Limited has sold Presmed Australia Pty Ltd (PMA) to ICG.
PMA is a private day hospital group founded in 1997. Since 2014, it is majority-owned by Advanced Health, with the rest of the company owned by the long-standing Australian management team, directors and a consortium of specialist doctors. PMA co-owns ten key operating assets, which include day hospitals and consultation clinics, in partnership with the practicing doctors in those facilities. The facilities are located in and around Sydney and the Central Coast, both within New South Wales, and Tasmania. PMA’s facilities specialize in a range of surgical disciplines such as ophthalmology, ear nose and throat, pain management and oral maxillofacial surgery, as well as other aligned surgery types.
Headquartered in London, UK, and with over 30 years’ history, ICG is a global alternative asset manager providing flexible capital solutions to help companies develop and grow. The firm manages US$68.5 billion of assets and invests across the capital structure. ICG was founded in 1989, is a FTSE250-listed company regulated by the Financial Conduct Authority, and has offices in 15 countries across Europe, Asia and the US.
Advanced Health Limited is a public company listed on the Johannesburg Stock Exchange. The majority of the shares (68%) are owned by entities associated with the owner and founder, Carl Grillenberger.
Oaklins’ team in South Africa acted as corporate and designated advisor to Advanced Health Limited in this transaction.
Sprechen Sie mit dem Deal Team
Annerie Britz
Oaklins South Africa
Transaktionen
Valmiermuižas Alus has been acquired by Cēsu Alus
Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.
Mehr erfahrenDie Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland
Die LabPoint Medizinische Laboratorien AG wurde von Affidea Switzerland AG übernommen. Mit Affidea hat die Lindenhofgruppe AG einen starken strategischen Partner für die Weiterentwicklung der LabPoint gewonnen. Die Lindenhofgruppe bleibt bedeutende Aktionärin und Grosskundin des Unternehmens. Damit schafft sie die Grundlage für eine nachhaltige Weiterentwicklung von LabPoint unter einer neuen Ankeraktionärin. LabPoint soll ihre Position in der Labordiagnostik weiter stärken und gezielt ausbauen.
Mehr erfahrenCapsol has been acquired by Angus Capital
Capsol has been acquired by Angus Capital as part of its strategy to build a leading construction services group alongside other portfolio companies. This partnership marks a new phase of growth for Capsol, providing the platform, resources and strategic support needed to accelerate its development and expand its market presence.
Mehr erfahren